BEHIND RIABNI™ The amgen experience YOU'VE COME to trust
BEHIND RIABNI™ The amgen experience YOU'VE COME to trust
Introducing Riabni™
The rituximab biosimilar from Amgen, a proven leader in oncology biologics1
Introducing Riabni™
The rituximab biosimilar from Amgen, a proven leader in oncology biologics1
- 1 week storage ONLY AVAILABLE WITH RIABNI™1-4
-
Proven biosimilar to Rituxan®1
- GROWING PORTFOLIO RIABNI™ IS THE 3RD AVAILABLE AMGEN ONCOLOGY BIOSIMILAR1,5,6
-
RIABNI™ has an established Q-CODE:
Q5123
RIABNI™ is FDA approved for all Rituxan® oncology indications1,2
-
Non-Hodgkin's lymphoma (NHL)
- - Follicular lymphoma (FL)
- - Previously untreated large B-cell lymphoma
- - Non-progressing (stable disease)
- Previously untreated chronic lymphocytic leukemia (CLL)
- FDA = Food and Drug Administration.